-transparent.png){kind=logo}
Although the target of the antimicrobial drug 1-methyl-2-nitro-5-vinylimidazole (MEV) has been shown to be DNA (Goldstein et al., 1977) the drug was ineffective in cell-free systems because it was not activated. Both the rate of metabolic activation of MEV and its antibacterial activity were increased when bacteria were grown in limiting oxygen. Mutants of Escherichia coli which were conditionally resistant to nitroimidazoles and nitrofurans were defective in drug activation. The activities of these drugs against E. coli correlated with their rates of metabolism. The antimicrobial spectrum of the drugs appeared to be related to their reducibility by different species.
Related Publications
B P Goldstein, and
R R Vidal-Plana, and
B Cavalleri, and
L Zerilli, and
G Carniti, and
L G Silvestri
June 1977,
Journal of general microbiology,
B P Goldstein, and
R R Vidal-Plana, and
B Cavalleri, and
L Zerilli, and
G Carniti, and
L G Silvestri
November 1961,
Pediatric clinics of North America,
B P Goldstein, and
R R Vidal-Plana, and
B Cavalleri, and
L Zerilli, and
G Carniti, and
L G Silvestri
August 1967,
Nature,
B P Goldstein, and
R R Vidal-Plana, and
B Cavalleri, and
L Zerilli, and
G Carniti, and
L G Silvestri
January 1948,
British medical bulletin,
B P Goldstein, and
R R Vidal-Plana, and
B Cavalleri, and
L Zerilli, and
G Carniti, and
L G Silvestri
January 1949,
Journal of general microbiology,
B P Goldstein, and
R R Vidal-Plana, and
B Cavalleri, and
L Zerilli, and
G Carniti, and
L G Silvestri
January 1957,
Actualites pharmacologiques,
B P Goldstein, and
R R Vidal-Plana, and
B Cavalleri, and
L Zerilli, and
G Carniti, and
L G Silvestri
January 1971,
Therapie,
B P Goldstein, and
R R Vidal-Plana, and
B Cavalleri, and
L Zerilli, and
G Carniti, and
L G Silvestri
February 1915,
British medical journal,
B P Goldstein, and
R R Vidal-Plana, and
B Cavalleri, and
L Zerilli, and
G Carniti, and
L G Silvestri
March 1962,
Archives de l'Institut Pasteur de Tunis,
B P Goldstein, and
R R Vidal-Plana, and
B Cavalleri, and
L Zerilli, and
G Carniti, and
L G Silvestri
November 2018,
Biointerphases,
